68 related articles for article (PubMed ID: 6130579)
1. [Mechanism of action of the new antibiotic kirromycin].
Sander G
Reprod Nutr Dev (1980); 1981; 21(2):185-92. PubMed ID: 6130579
[TBL] [Abstract][Full Text] [Related]
2. Synthetic analogs of aurodox and kirromycin active on elongation factor Tu from Escherichia coli.
Chinali G
J Antibiot (Tokyo); 1981 Aug; 34(8):1039-45. PubMed ID: 6119303
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of action of kirromycin-like antibiotics.
Parmeggiani A; Swart GW
Annu Rev Microbiol; 1985; 39():557-77. PubMed ID: 3904612
[No Abstract] [Full Text] [Related]
4. The antibiotics kirromycin and pulvomycin bind to different sites on the elongation factor Tu from Escherichia coli.
Pingoud A; Block W; Urbanke C; Wolf H
Eur J Biochem; 1982 Apr; 123(2):261-5. PubMed ID: 6122571
[TBL] [Abstract][Full Text] [Related]
5. Synergism between the GTPase activities of EF-Tu.GTP and EF-G.GTP on empty ribosomes. Elongation factors as stimulators of the ribosomal oscillation between two conformations.
Mesters JR; Potapov AP; de Graaf JM; Kraal B
J Mol Biol; 1994 Oct; 242(5):644-54. PubMed ID: 7932721
[TBL] [Abstract][Full Text] [Related]
6. Effect of kirromycin on elongation factor Tu. Location of the catalytic center for ribosome-elongation-factor-Tu GTPase activity on the elongation factor.
Chinali G; Wolf H; Parmeggiani A
Eur J Biochem; 1977 May; 75(1):55-65. PubMed ID: 193689
[No Abstract] [Full Text] [Related]
7. The structural and functional basis for the kirromycin resistance of mutant EF-Tu species in Escherichia coli.
Mesters JR; Zeef LA; Hilgenfeld R; de Graaf JM; Kraal B; Bosch L
EMBO J; 1994 Oct; 13(20):4877-85. PubMed ID: 7525272
[TBL] [Abstract][Full Text] [Related]
8. The GTPase activity of elongation factor Tu and the 3'-terminal end of aminoacyl-tRNA.
Parlato G; Guesnet J; Crechet JB; Parmeggiani A
FEBS Lett; 1981 Mar; 125(2):257-60. PubMed ID: 6112171
[No Abstract] [Full Text] [Related]
9. Functional role of the noncatalytic domains of elongation factor Tu in the interactions with ligands.
Cetin R; Anborgh PH; Cool RH; Parmeggiani A
Biochemistry; 1998 Jan; 37(2):486-95. PubMed ID: 9425069
[TBL] [Abstract][Full Text] [Related]
10. Enacyloxin IIa, an inhibitor of protein biosynthesis that acts on elongation factor Tu and the ribosome.
Cetin R; Krab IM; Anborgh PH; Cool RH; Watanabe T; Sugiyama T; Izaki K; Parmeggiani A
EMBO J; 1996 May; 15(10):2604-11. PubMed ID: 8665868
[TBL] [Abstract][Full Text] [Related]
11. The mechanism of action of virginiamycin M on the binding of aminoacyl-tRNA to ribosomes directed by elongation factor Tu.
Chinali G; Moureau P; Cocito CG
Eur J Biochem; 1981 Sep; 118(3):577-83. PubMed ID: 6117464
[No Abstract] [Full Text] [Related]
12. Characterization of a kirromycin-resistant elongation factor Tu from Escherichia coli.
Ivell R; Fasano O; Crechet JB; Parmeggiani A
Biochemistry; 1981 Mar; 20(5):1355-61. PubMed ID: 7013793
[TBL] [Abstract][Full Text] [Related]
13. The G222D mutation in elongation factor Tu inhibits the codon-induced conformational changes leading to GTPase activation on the ribosome.
Vorstenbosch E; Pape T; Rodnina MV; Kraal B; Wintermeyer W
EMBO J; 1996 Dec; 15(23):6766-74. PubMed ID: 8978702
[TBL] [Abstract][Full Text] [Related]
14. The mode of action of nosiheptide (multhiomycin) and the mechanism of resistance in the producing organism.
Cundliffe E; Thompson J
J Gen Microbiol; 1981 Sep; 126(1):185-92. PubMed ID: 7038038
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of the inhibition of protein synthesis by kirromycin. Role of elongation factor Tu and ribosomes.
Wolf H; Chinali G; Parmeggiani A
Eur J Biochem; 1977 May; 75(1):67-75. PubMed ID: 324765
[No Abstract] [Full Text] [Related]
16. Identification of the part of kirromycin structure that acts on elongation factor Tu.
Chinali G
FEBS Lett; 1981 Aug; 131(1):94-8. PubMed ID: 6116624
[No Abstract] [Full Text] [Related]
17. Elongation factor Tu1 of the antibiotic GE2270A producer Planobispora rosea has an unexpected resistance profile against EF-Tu targeted antibiotics.
Möhrle VG; Tieleman LN; Kraal B
Biochem Biophys Res Commun; 1997 Jan; 230(2):320-6. PubMed ID: 9016775
[TBL] [Abstract][Full Text] [Related]
18. Effects of elfamycins on elongation factor Tu from Escherichia coli and Staphylococcus aureus.
Hall CC; Watkins JD; Georgopapadakou NH
Antimicrob Agents Chemother; 1989 Mar; 33(3):322-5. PubMed ID: 2499247
[TBL] [Abstract][Full Text] [Related]
19. Inhibition by thiopeptin of bacterial protein synthesis.
Liou YF; Kinoshita T; Tanaka N
Jpn J Microbiol; 1976 Jun; 20(3):233-40. PubMed ID: 787605
[TBL] [Abstract][Full Text] [Related]
20. Allosteric changes of the guanine nucleotide site of elongation factor EF-Tu: a comparative study of two kirromycin-resistant EF-Tu species.
Swart GW; Kraal B; Bosch L; Parmeggiani A
FEBS Lett; 1982 Jun; 142(1):101-6. PubMed ID: 6125410
[No Abstract] [Full Text] [Related]
[Next] [New Search]
